Healthy Volunteer Study Using 3 Different Formulations of Firategrast
Status:
Completed
Trial end date:
2011-09-17
Target enrollment:
Participant gender:
Summary
This study will investigate how 3 types of drug formulations are absorbed by the body. This
study is termed 'open-label', which means volunteers will be aware of which treatment they
are receiving. The study is split into 2 parts. Part 1, involves volunteers receiving 2 new
formulations, as a single dose. There is no placebo (dummy-drug; no active ingredient) in
this study. Volunteers will also receive a single dose of a formulation used in previous
trials (reference formulation), so a proper comparison with the new formulations can be made.
The new fomulations will be administered with food and the reference formulation will be
given without food. In Part 2, volunteers will receive only one of the 3 formulations as a
repeat dose for 7 days. Each of these doses will be given with food.